Atomic‐Precision Triple‐Enzyme Nanozyme Synchronizes Mitochondrial Dual‐Pathway Disruption for Precision Oncology
Angewandte Chemie International Edition · 23.02.2026 · 65 (9)
DOI: 10.1002/anie.202520859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 20.01.2026. Verfasst von Yufan Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Marshall Laboratory of Biomedical Engineering, Research Center for Biosensor and Nanotheranostic, School of Biomedical Engineering, Health Science Ce…. Hauptthemen laut MEDLINE: Mitochondria. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Shenzhen Medical Research Fund, National Natural Science Foundation of China, Guangdong Province Pearl River Team.
Abstract (Originalsprache)
Although nanozyme‐mediated disruption of mitochondrial homeostasis holds significant therapeutic potential, precise spatiotemporal regulation using single‐function catalysts remains a major challenge. To overcome this limitation, we developed a triphenylphosphine‐functionalized Pd@PtIr nanozyme by epitaxially depositing a Pt–Ir (1:1) alloy shell onto Pd nanocube cores with atomic‐level precision. This rationally engineered metal‐center architecture generates a synergistic catalytic interface that not only enhances peroxidase‐like activity—validated by density functional theory (DFT)—but also endows the nanozyme with intrinsic NADH oxidase and glutathione peroxidase‐like functionalities within a single platform. Upon 808 nm near‐infrared (NIR) irradiation, the nanozyme triggers a cascade of enzyme‐mimetic redox reactions that jointly deplete mitochondrial glutathione (GSH) and elevate reactive oxygen species (ROS) levels, while NADH oxidation concurrently disrupts ATP biosynthesis. These concerted effects synergistically impair mitochondrial redox homeostasis and energy metabolism in tumor cells. To further potentiate therapeutic efficacy, we combined the nanozyme with antisense oligonucleotide‐mediated silencing of ASncmtRNA, resulting in a pronounced 89.1% tumor regression in an orthotopic breast cancer model. This integrated approach—combining atomic‐precision catalyst design, multifunctional enzymatic activity, and gene‐silencing therapy—presents a transformative paradigm for organelle‐targeted precision nanotherapeutics in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marshall Laboratory of Biomedical Engineering, Research Center for Biosensor and Nanotheranostic, School of Biomedical Engineering, Health Science Center, Shenzhen University, Guangdong, 518060, P.R. China.
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P.R. China.
- Research Center for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science & Technology Beijing, Beijing, 100083, P.R. China.
- School of Material & Environmental Engineering, Shenzhen Polytechnic University, Shenzhen, 518055, P.R. China.
Förderung
- Shenzhen Medical Research Fund
- National Natural Science Foundation of China
- Guangdong Province Pearl River Team
- Shenzhen Key Laboratory for Nano-Biosensing Technology
Zitieren
APA
Zhang, Y., Yang, S., Xiang, Q., Huang, J., Tan, Y., Peng, X., Feng, Y., Chang, R., Li, J., Cheng, Y., Wang, X., Gao, Z., & Dong, H. (2026). Atomic‐Precision Triple‐Enzyme Nanozyme Synchronizes Mitochondrial Dual‐Pathway Disruption for Precision Oncology. Angewandte Chemie International Edition, 65(9). https://doi.org/10.1002/anie.202520859
Vancouver
Zhang Y, Yang S, Xiang Q, Huang J, Tan Y, Peng X, et al. Atomic‐Precision Triple‐Enzyme Nanozyme Synchronizes Mitochondrial Dual‐Pathway Disruption for Precision Oncology. Angewandte Chemie International Edition. 2026;65(9). doi:10.1002/anie.202520859
BibTeX
@article{Zhang2026,
author = {Zhang, Yufan and Yang, Shuangshuang and Xiang, Qin and Huang, Jinkun and Tan, Yongfeng and Peng, Xiang and Feng, Youming and Chang, Ran and Li, Jinze and Cheng, Yaru and Wang, Xuan and Gao, Zhuangqiang and Dong, Haifeng},
title = {Atomic‐Precision Triple‐Enzyme Nanozyme Synchronizes Mitochondrial Dual‐Pathway Disruption for Precision Oncology},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {9},
doi = {10.1002/anie.202520859}
}
EUVIMED